Abigail Beaney

Data from Verrica’s trial showed that 51% of patients achieved complete histologic clearance, but investors were not happy.

The FDA rejected the therapy after the AdComm raised efficacy and ethical concerns in Lykos' trials.

The agency put a pause on the Phase I trial due to safety concerns with neutrophil count and mucositis events after three patients died.

The agency put a pause on the Phase I trial due to safety concerns with neutrophil count and mucositis events after three patients died.

The recent data showed a 94% reduction in risk of developing type 2 diabetes after three years of treatment with Zepbound.

For small and medium-sized biotech's, for many years the common practice has been to outsource to both contract research organisations (CROs) and

Nykode is scrapping development of its cancer vaccine in second-line cervical cancer to save $25m.

Abigail Beaney 3 min read In This Article Arrowhead Pharmaceuticals is looking to file a new drug application (NDA) with

Roche has three ongoing Phase III trials of its BTK inhibitor fenebrutinib in patients with relapsing multiple sclerosis.

Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-1769 in healthy participants.